Australia markets closed

Brii Biosciences Limited (2137.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.010-0.010 (-0.98%)
At close: 04:08PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-174,829
-174,829
-484,312
-4,163,849
-1,189,600
-
Depreciation & amortisation
15,674
15,674
17,032
17,262
14,209
-
Stock-based compensation
64,223
64,223
77,928
79,370
29,483
-
Change in working capital
-120,733
-120,733
-76,994
-333,742
471,450
-
Other working capital
-643,622
-643,622
-635,571
-880,486
-403,716
-
Other non-cash items
-107,529
-107,529
-36,353
3,593,532
349,633
-
Net cash provided by operating activities
-594,014
-594,014
-496,279
-879,457
-403,716
-
Cash flows from investing activities
Investments in property, plant and equipment
-49,608
-49,608
-139,292
-1,029
-
-24,147
Purchases of investments
-3,487,006
-3,487,006
-2,101,905
-499,647
-196,228
-
Sales/maturities of investments
3,268,132
3,268,132
774,813
20,107
153,698
-
Other investing activities
1,146
1,146
-1,426
3,190
-3,527
-
Net cash used for investing activities
-104,350
-104,350
-1,433,168
-475,756
-43,650
-
Net change in cash
-709,341
-709,341
-1,932,489
1,874,921
209,635
-
Cash at beginning of period
1,190,572
1,190,572
2,855,093
1,034,965
880,359
-
Cash at end of period
489,650
489,650
1,190,572
2,855,093
1,034,965
-
Free cash flow
Operating cash flow
-594,014
-594,014
-496,279
-879,457
-403,716
-
Capital expenditure
-49,608
-49,608
-139,292
-1,029
-
-24,147
Free cash flow
-643,622
-643,622
-635,571
-880,486
-403,716
-